TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
$10.87
arrow_downward
-4.82%(-0.55) 1D
$11.00
arrow_upward
+1.21% (+0.13)bedtimeAfter hours
Closed: Sep 18, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNXP...
Open
$11.43
High
$11.47
Low
$10.80
Mkt. cap
186.43M
Avg. vol.
452.61K
Volume
808.47K
52-wk high
$28.42
52-wk low
$9.40
EPS
-$12.92
Beta
1.74
Shares outstanding
17.15M
No. of employees
142
Open
$11.43
High
$11.47
Low
$10.80
Mkt. cap
186.43M
Avg. vol.
452.61K
Volume
808.47K
52-wk high
$28.42
52-wk low
$9.40
EPS
-$12.92
Beta
1.74
Shares outstanding
17.15M
No. of employees
142
News stories
From web sources and news partners
CarePlus VietNam
·
2 months ago
TNXP Q1 2026 Earnings: EPS Falls Short of Estimates as Pre-Revenue Biotech Advances Clinical Pipeline
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees142
Founded2007
HeadquartersBerkeley Heights, New Jersey, United States
SectorBiotechnology
Websitetonixpharma.com